Results 291 to 300 of about 2,828,087 (336)

CEP290 deficiency disrupts ciliary axonemal architecture in human iPSC-derived brain organoids. [PDF]

J Cell Sci
Eschment M, Mercey O, Aarts EM, Perego L, Figueiro-Silva J, Mennel M, Abidi A, Generali M, Rauch A, Guichard P, Hamel V, Bachmann-Gagescu R.   +11 more
europepmc   +1 more source

Rethinking plastic waste: innovations in enzymatic breakdown of oil‐based polyesters and bioplastics

FEBS Open Bio, EarlyView.
Plastic pollution remains a critical environmental challenge, and current mechanical and chemical recycling methods are insufficient to achieve a fully circular economy. This review highlights recent breakthroughs in the enzymatic depolymerization of both oil‐derived polyesters and bioplastics, including high‐throughput protein engineering, de novo ...
Elena Rosini, Nicolò Antonelli, Gianluca Molla   +2 more
wiley   +1 more source

Integrated transcriptomic and lipidomic analyses reveal altered lipid homeostasis in mutant FUS^P525L astrocytes from HiPSCs. [PDF]

J Transl Med
Zhu Y, Huang J, Neyrinck K, Liu M, Yang T, Ahuja K, Chai YC.   +6 more
europepmc   +1 more source

Interplay between RNA‐protein interactions and RNA structures in gene regulation

FEBS Open Bio, EarlyView.
Methodological advances in mapping transcriptome‐wide RNA‐protein interactions and RNA structures have started to uncover the potential of RNP conformations in gene regulation. Competing RNA–RNA, RNA‐protein and protein–protein interactions shape the compaction and function of RNPs throughout their lifetime and may provide novel therapeutic targets in ...
Jenni Rapakko, Mauro Scaravilli, Minna‐Liisa Änkö   +2 more
wiley   +1 more source

Cellular activity upregulation of the thermolabile p53 cancer mutant Y220C by small molecule indazole derivatives. [PDF]

Cell Death Discov
Khadiullina R, Chasov V, Gilyazova E, Davletshin D, Mirgayazova R, Mingaleeva R, Stephenson Clarke JR, Baud MG, Bulatov E.   +8 more
europepmc   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source

Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation. [PDF]

Arterioscler Thromb Vasc Biol
Schrenk S, Sherpa C, Bischoff LJ, Cai Y, Boscolo E.   +4 more
europepmc   +1 more source

Overexpression of CDT1 inhibits cell cycle progression at S phase by interacting with the mini‐chromosome maintenance complex and causes DNA damage

FEBS Open Bio, EarlyView.
CDT1 is an essential protein for DNA replication licensing that loads the MCM complex, the eukaryotic replicative DNA helicase, onto replication origins. Overexpression of CDT1 induces cell cycle arrest at the S phase. Here we showed CDT1 inhibits the progression of replication forks by interacting with the MCM complex, leading to the stalling and ...
Takashi Tsuyama, Nonoka Takayama, Rina Tanaka, Yuuki Arai, Yohko Yamaguchi, Yuko Nawata, Yutaro Azuma, Shusuke Tada   +7 more
wiley   +1 more source

How a Melanism Mutant Responds to Different Temperatures: A Case Study in Ladybird Beetle <i>Harmonia axyridis</i> Demonstrating Thermal-Induced Phenotypic Plasticity. [PDF]

Ecol Evol
Sun YX, Zhang CL, Wang SS, Ma RY, Li XW, Hao YN, Kong WN.   +6 more
europepmc   +1 more source

A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms

FEBS Open Bio, EarlyView.
We developed a general enzyme kinetic model that integrates these six basic inhibition mechanism onto a single one. From this model, we deduced a general enzyme kinetic equation that through modulation of simple parameters, γ (the relative inhibitor affinity for two binding sites) and β (the reactivity of the enzyme–substrate–inhibitor complex), is ...
Rafael S. Chagas, Sandro R. Marana
wiley   +1 more source